Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Svenja Siemer"'
Autor:
Svenja Siemer, Torsten Fauth, Paul Scholz, Yara Al-Zamel, Aya Khamis, Désirée Gül, Laura Freudelsperger, Barbara Wollenberg, Sven Becker, Roland H. Stauber, Jan Hagemann
Publikováno v:
Cancers, Vol 13, Iss 19, p 4831 (2021)
Treatment success of head and neck cancers (HNSCC) is often hindered by tumor relapses due to therapy resistances. This study aimed at profiling cisplatin resistance mechanisms and identifying biomarkers potentially suitable as drug targets and for p
Externí odkaz:
https://doaj.org/article/7a59893a14744d15b6090d2daed5612d
Autor:
Panagiotis Efentakis, Hendrik Doerschmann, Claudius Witzler, Svenja Siemer, Panagiota-Efstathia Nikolaou, Efstathios Kastritis, Roland Stauber, Meletios Athanasios Dimopoulos, Philip Wenzel, Ioanna Andreadou, Evangelos Terpos
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 15, p 5185 (2020)
Background: Carfilzomib’s (Cfz) adverse events in myeloma patients include cardiovascular toxicity. Since carfilzomib’s vascular effects are elusive, we investigated the vascular outcomes of carfilzomib and metformin (Met) coadministration. Metho
Externí odkaz:
https://doaj.org/article/f86136bf69604c8488d656a5c7bea6ef
Autor:
Svenja Siemer, Désirée Wünsch, Aya Khamis, Qiang Lu, Arnaud Scherberich, Miriam Filippi, Marie Pierre Krafft, Jan Hagemann, Carsten Weiss, Guo-Bin Ding, Roland H. Stauber, Alena Gribko
Publikováno v:
Nanomaterials, Vol 10, Iss 2, p 383 (2020)
Nanomaterials have great potential for the prevention and treatment of cancer. Circulating tumor cells (CTCs) are cancer cells of solid tumor origin entering the peripheral blood after detachment from a primary tumor. The occurrence and circulation o
Externí odkaz:
https://doaj.org/article/f6d696d9ce64410c9876564d0419025a
Autor:
Tobias A. Bauer, Jonas Schramm, Federico Fenaroli, Svenja Siemer, Christine I. Seidl, Christine Rosenauer, Regina Bleul, Roland H. Stauber, Kaloian Koynov, Michael Maskos, Matthias Barz
Publikováno v:
Advanced Materials, 35(21):2210704
Translating innovative nanomaterials to medical products requires efficient manufacturing techniques that enable large-scale high-throughput synthesis and high reproducibility. Drug carriers in medicine embrace a complex subset of tasks calling for m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ae3eff20ed460d118252bbde5eefb3
https://doi.org/10.1002/adma.202210704
https://doi.org/10.1002/adma.202210704
Autor:
Moritz Brandt, Hendrik Dörschmann, Sana’a Khraisat, Tanja Knopp, Julia Ringen, Sanela Kalinovic, Venkata Garlapati, Svenja Siemer, Michael Molitor, Sebastian Göbel, Roland Stauber, Susanne Helena Karbach, Thomas Münzel, Andreas Daiber, Philip Wenzel
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 79(10)
Background: Heart failure (HF) coincides with cardiomyocyte telomere shortening. Arterial hypertension is the most prominent risk factor for HF. Both HF and arterial hypertension are associated with dysregulation of the neurohormonal axis. How neuroh
Autor:
Donata Gellrich, Dimo Dietrich, Christoph A. Reichel, Shirley K. Knauer, Jonas Eckrich, Timon Hussain, Sebastian Strieth, Roland H. Stauber, Svenja Siemer
Publikováno v:
Tissue Engineering and Regenerative Medicine
Background: To improve the biocompatibility of porous polyethylene (PPE) implants and expand their application range for reconstructive surgery in poorly vascularized environments, implants were coated with tumor necrosis factor α (TNFα) inhibitor
Autor:
Sven Becker, Christina Breder, Svenja Siemer, Christine Rosenauer, Federico Fenaroli, Matthias Barz, Sebastian Strieth, Dimo Dietrich, Jörn Dietrich, Torsten Fauth, Gregory Harms, Roland H. Stauber, Tobias A. Bauer, Christoph Reinhardt, Paul Scholz, Jan Hagemann
Publikováno v:
ACS Nano, 15(11), 18541–18556
Therapy resistance is the major cause of cancer death. As patients respond heterogeneously, precision/personalized medicine needs to be considered, including the application of nanoparticles (NPs). The success of therapeutic NPs requires to first ide
Autor:
Jörg Steinmann, Dana Westmeier, Roland H. Stauber, Cecilia Vallet, Jan Buer, Shirley K. Knauer, Svenja Siemer
Publikováno v:
Materials Today. 26:19-29
This article has been removed: please see Elsevier Policy on Article Withdrawal ( https://www.elsevier.com/about/our-business/policies/article-withdrawal ). This article has been removed at the request of the Editors. Parts of Figure 1 were obtained
Autor:
Jonas Eckrich, Christof Seckert, Svenja Siemer, Désirée Wünsch, Chengfang Pang, Mike Hasenberg, Roland H. Stauber, Dominic Docter, Sebastian Strieth, Matthias Barz, Christian Thyssen, Dana Westmeier, Oliver Schilling, Shirley K. Knauer
Publikováno v:
Biomaterials. 192:551-559
Multidrug-resistant bacterial infections are a global health threat. Nanoparticles are thus investigated as novel antibacterial agents for clinical practice, including wound dressings and implants. We report that nanoparticles' bactericidal activity
Autor:
Svenja Siemer, Claudius Witzler, Evangelos Terpos, Ioanna Andreadou, Panagiota-Efstathia Nikolaou, Philip Wenzel, Efstathios Kastritis, Hendrik Doerschmann, Roland H. Stauber, Meletios A. Dimopoulos, Panagiotis Efentakis
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 15
International Journal of Molecular Sciences, Vol 21, Iss 5185, p 5185 (2020)
Volume 21
Issue 15
International Journal of Molecular Sciences, Vol 21, Iss 5185, p 5185 (2020)
Background: Carfilzomib&rsquo
s (Cfz) adverse events in myeloma patients include cardiovascular toxicity. Since carfilzomib&rsquo
s vascular effects are elusive, we investigated the vascular outcomes of carfilzomib and metformin (Met) coadm
s (Cfz) adverse events in myeloma patients include cardiovascular toxicity. Since carfilzomib&rsquo
s vascular effects are elusive, we investigated the vascular outcomes of carfilzomib and metformin (Met) coadm